332 related articles for article (PubMed ID: 18078629)
1. Sustained success of therapy with inhaled iloprost for severe pulmonary arterial hypertension associated with systemic sclerosis and pulmonary fibrosis.
Ahmadi-Simab K; Köhler A; Gross WL
Clin Exp Rheumatol; 2007; 25(5):760-2. PubMed ID: 18078629
[TBL] [Abstract][Full Text] [Related]
2. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
3. Successful therapy of bosentan-refractory pulmonary arterial hypertension (PAH) with inhalative iloprost.
Ahmadi-Simab K; Lamprecht P; Gross WL
Clin Exp Rheumatol; 2005; 23(3):402-3. PubMed ID: 15971433
[TBL] [Abstract][Full Text] [Related]
4. Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension.
Hoeper MM; Leuchte H; Halank M; Wilkens H; Meyer FJ; Seyfarth HJ; Wensel R; Ripken F; Bremer H; Kluge S; Hoeffken G; Behr J
Eur Respir J; 2006 Oct; 28(4):691-4. PubMed ID: 17012628
[TBL] [Abstract][Full Text] [Related]
5. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
6. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.
McLaughlin VV; Oudiz RJ; Frost A; Tapson VF; Murali S; Channick RN; Badesch DB; Barst RJ; Hsu HH; Rubin LJ
Am J Respir Crit Care Med; 2006 Dec; 174(11):1257-63. PubMed ID: 16946127
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of long-term oral monotherapy and additional effect of inhaled iloprost in patients with severe idiopathic pulmonary arterial hypertension].
Onen ZP; Sayın T; Akkoca Yıldız O; Ozdemir Kumbasar O; Karabıyıkoğlu G
Anadolu Kardiyol Derg; 2010 Oct; 10(5):458-60. PubMed ID: 20929705
[No Abstract] [Full Text] [Related]
8. [Pulmonary arterial hypertension and systemic sclerosis].
Launay D; Humbert M; Hachulla E
Presse Med; 2006 Dec; 35(12 Pt 2):1929-37. PubMed ID: 17159719
[TBL] [Abstract][Full Text] [Related]
9. Possible anti-metastatic effect of iloprost in a patient with systemic sclerosis with lung cancer: a case study.
Pehlivan Y; Turkbeyler IH; Balakan O; Sevinc A; Yilmaz M; Bakir K; Onat AM
Rheumatol Int; 2012 May; 32(5):1437-41. PubMed ID: 21448647
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe pulmonary hypertension secondary to scleroderma: a three-drug approach.
Catapano-Minotti G; Corsonello A; Guadalupi G; Spani R; Antonelli-Incalzi R
Intern Med; 2008; 47(6):511-3. PubMed ID: 18344637
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
12. [Effect of nebulised iloprost combined with inhaled nitric oxide and oral sildenafil on lung transplant patients. Therapeutic efficacy in pulmonary hypertension during surgery].
Rabanal Llevot JM; Cimadevilla Calvo B; Cifrian Martinez JM; Ruisanchez Villar C; Mons Lera R
Rev Esp Anestesiol Reanim; 2012 Mar; 59(3):142-9. PubMed ID: 22985755
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension.
Hoeper MM; Spiekerkoetter E; Westerkamp V; Gatzke R; Fabel H
Eur Respir J; 2002 Aug; 20(2):339-43. PubMed ID: 12212965
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
[TBL] [Abstract][Full Text] [Related]
15. Experience with inhaled iloprost and bosentan in portopulmonary hypertension.
Hoeper MM; Seyfarth HJ; Hoeffken G; Wirtz H; Spiekerkoetter E; Pletz MW; Welte T; Halank M
Eur Respir J; 2007 Dec; 30(6):1096-102. PubMed ID: 17652314
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Pulmonary Arterial Hypertension Using Initial Combination Therapy of Bosentan and Iloprost.
Han X; Zhang Y; Dong L; Fang L; Chai Y; Niu M; Yu Y; Liu L; Yang X; Qu S; Li S
Respir Care; 2017 Apr; 62(4):489-496. PubMed ID: 28119496
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.
Ivy DD; Doran AK; Smith KJ; Mallory GB; Beghetti M; Barst RJ; Brady D; Law Y; Parker D; Claussen L; Abman SH
J Am Coll Cardiol; 2008 Jan; 51(2):161-9. PubMed ID: 18191742
[TBL] [Abstract][Full Text] [Related]
18. Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass.
Theodoraki K; Rellia P; Thanopoulos A; Tsourelis L; Zarkalis D; Sfyrakis P; Antoniou T
Can J Anaesth; 2002 Nov; 49(9):963-7. PubMed ID: 12419726
[TBL] [Abstract][Full Text] [Related]
19. Inhaled iloprost in pulmonary arterial hypertension.
Baker SE; Hockman RH
Ann Pharmacother; 2005; 39(7-8):1265-74. PubMed ID: 15976392
[TBL] [Abstract][Full Text] [Related]
20. Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy.
Seyfarth HJ; Pankau H; Hammerschmidt S; Schauer J; Wirtz H; Winkler J
Chest; 2005 Aug; 128(2):709-13. PubMed ID: 16100158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
